Type 2 Diabetes Archive

Preoperative Liraglutide May Stabilize Postoperative Plasma Glucose in T2D

Preoperative Liraglutide May Stabilize Postoperative Plasma Glucose in T2D

For patients with type 2 diabetes undergoing non-cardiac surgery, premedication with liraglutide is associated with reduced median plasma glucose 1 hour postoperatively.

Diabetes Treatments

Antidiabetic agents for the treatment of diabetes including maintenance and max doses.

Glucose-Responsive Exendin-4 Delivery Device for T2D Holds Promise

Glucose-Responsive Exendin-4 Delivery Device for T2D Holds Promise

A smart exendin-4 delivery device is a promising therapeutic option for type 2 diabetes that can provide safe, long-term, and on-demand Ex4 therapy.

FDA Approves First Shock Wave Device for Treating Diabetic Foot Ulcers

FDA Approves First Shock Wave Device for Treating Diabetic Foot Ulcers

The FDA has granted marketing clearance of the first shock wave device intended for use in the treatment of chronic, full-thickness diabetic foot ulcers.

Intensive Blood Pressure Lowering Reduces CV Events Similarly in Patients With/Without T2D

Intensive Blood Pressure Lowering Reduces CV Events Similarly in Patients With/Without T2D

Researchers assessed the effect of both type 2 diabetes and baseline cardiovascular disease risk on the treatment effect of intensive blood pressure lowering based on data and pooled analysis from 14,094 patients.

CV Event Prediction, Risk Assessment in Type 2 Diabetes

CV Event Prediction, Risk Assessment in Type 2 Diabetes

Risk of cardiovascular events in people with type 2 diabetes and subgroups of coronary artery disease was examined.

FDA Approves 3 New Drugs for T2D in Adults

FDA Approves 3 New Drugs for T2D in Adults

Steglatro is indicated as adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and Steglujan is indicated as adjunct when treatment with both ertugliflozin and sitagliptin are appropriate.

Positive Antihyperglycemic, Metabolic Effects With Ranolazine in Patients With Diabetes

Positive Antihyperglycemic, Metabolic Effects With Ranolazine in Patients With Diabetes

While there is increasing positive data for the utilization of ranolazine, a majority of the data did not come from large randomized controlled trials that looked at metabolic parameters as their primary end point.

Corticosteroids Linked With Risk for Fracture, VTE, Sepsis in Diabetes

Corticosteroids Linked With Risk for Fracture, VTE, Sepsis in Diabetes

Corticosteroids should be used with caution in patients with diabetes and mitigating factors should be considered.

Alogliptin Associated With Lower Fracture Risk Than Linagliptin, Saxagliptin in T2D

Alogliptin Associated With Lower Fracture Risk Than Linagliptin, Saxagliptin in T2D

Network meta-analysis provided some information on differences between DPP-4 inhibitors, traditional anti-diabetes agents, and placebo in bone fracture.

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

Patients from 3 sites participated in a trial examining the noninferiority of telemedicine vs standard outpatient care for diabetic foot ulcer follow-up treatment.

Urinary Albumin-to-Creatinine Ratio Aids CV Risk Assessment in T2D

Urinary Albumin-to-Creatinine Ratio Aids CV Risk Assessment in T2D

Urinary albumin-to-creatinine ratio can be independently associated with various adverse CV outcomes.

Optimal Dose of Linagliptin Determined for Pediatric T2D

Optimal Dose of Linagliptin Determined for Pediatric T2D

Study sought to determine the optimal dosing of linagliptin for the treatment of children with type 2 diabetes.

Measuring Quality of Life Important When Evaluating Diabetes Treatments

Measuring Quality of Life Important When Evaluating Diabetes Treatments

Patients with diabetes report worse quality of life with more intensified treatment, demonstrating the importance of measuring quality of life outcomes when evaluating diabetes treatments.

Prediabetes Diagnosis Categorized as Diabetes With 2-Hour Plasma Glucose Test

Prediabetes Diagnosis Categorized as Diabetes With 2-Hour Plasma Glucose Test

Investigators sought to examine whether individuals with prediabetes, based on A1c and fasting plasma glucose levels, would have a diagnosis of diabetes when using a 2-hour plasma glucose test.

Coronary Artery Bypass Grafting: Preferred Method of Revascularization in Diabetes

Coronary Artery Bypass Grafting: Preferred Method of Revascularization in Diabetes

In patients with diabetes, coronary artery bypass grafting may be the preferred method of revascularization, with lower rates of major adverse cardiac or cerebrovascular events.

No Interaction Among Dietary/Genetic Variables, Iron Status, T2D Risk

No Interaction Among Dietary/Genetic Variables, Iron Status, T2D Risk

No convincing evidence that the interplay of dietary and genetic factors related to body iron status associates with the risk of type 2 diabetes above the level expected.

Glycemic Control Variations With Biphasic Insulin Aspart vs Basal-Bolus Therapy

Glycemic Control Variations With Biphasic Insulin Aspart vs Basal-Bolus Therapy

A randomized controlled trial evaluated whether treatment intensification with biphasic insulin aspart 30 improved glycemic control in patients with type 2 diabetes.

Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes

Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes

There were no significant differences in coronary disease-specific health status or dyspnea benefits of chronic total occlusion PCI in patients with and without diabetes.

Severe Hypoglycemia Linked to High Risk for CV Events in Adults With T2D

Severe Hypoglycemia Linked to High Risk for CV Events in Adults With T2D

Findings from a new study suggest that episodes of severe hypoglycemia in patients with diabetes are associated with high rates of subsequent cardiovascular events.

Physical Activity, Sedentary Time May Increase Cardiometabolic Risk Markers in Prediabetes

Physical Activity, Sedentary Time May Increase Cardiometabolic Risk Markers in Prediabetes

A study sought to clarify whether total physical activity during the day is equally as important as achieving high levels of intensity associated with moderate-to-vigorous physical activity.

One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements

One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements

A prospective cohort study was conducted to determine if 1 hour vs 2 hour blood glucose levels were better for predicting the development of type 2 diabetes.

More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes

More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes

Patients with diabetes taking saxagliptin, sitagliptin, second-generation sulfonylureas, pioglitazone, and long-acting insulin were assessed for the risk of acute myocardial infarction.

Elderly Patients With T2D, Heart Failure Have High Risk for Mortality

Elderly Patients With T2D, Heart Failure Have High Risk for Mortality

A strong association was found in study between poor survival in elderly patients with type 2 diabetes and cardiovascular complications, especially heart failure.

FDA Approves Admelog Short-Acting Insulin Lispro Injection

FDA Approves Admelog Short-Acting Insulin Lispro Injection

Drug approval was granted through an abbreviated approval pathway, based on Humalog clinical data.

HbA1c Predicts Risk for T2D in African American, White Patients

HbA1c Predicts Risk for T2D in African American, White Patients

Investigators believe that type 2 diabetes risk assessment would be optimal with fasting glucose and HbA1c levels.

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

A remotely connected diabetes management system increased patent satisfaction and improved glycemic control in patients with insulin-treated diabetes.

Insulin Associated With BMD Loss at Femoral Neck in Women With T2D

Insulin Associated With BMD Loss at Femoral Neck in Women With T2D

Bone mineral density was evaluated annually of the lumbar spine and femoral neck.

DPP4 Inhibitors Provide Greater Long-Term Glycemic Control Than Sulfonylureas

DPP4 Inhibitors Provide Greater Long-Term Glycemic Control Than Sulfonylureas

Investigators discuss an added benefit of using DPP4 inhibitors would be a lower incidence of hypoglycemia.

FDA: Semaglutide Approval for Adults With T2D

FDA: Semaglutide Approval for Adults With T2D

Semaglutide, a once-weekly GLP-1 receptor agonist, demonstrated clinically significant reductions in HbA1c among adults with type 2 diabetes.

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

The Food and Drug Administration has posted a recall notification for 2 lots of Riomet 500mg/5mL due to the possibility that the liquid may be contaminated with Scopulariopsis brevicaulis.

Insulin-Induced Weight Gain Not Associated With Adverse CV Outcomes in T2D

Insulin-Induced Weight Gain Not Associated With Adverse CV Outcomes in T2D

Despite the well‐recognized correlation between weight gain and cardiovascular (CV) disease, there is little direct evidence relating to the impact of insulin‐induced weight gain on CV outcomes.

Incident Diabetes May Explain Association Between Sleep Duration and CHD

Incident Diabetes May Explain Association Between Sleep Duration and CHD

Interventions targeting sleep duration could have a significant impact on health outcomes when considering the importance of diabetes for a wide range of diseases.

Renal Outcomes in T2D With Intensive Glycemic Control in Veterans

Renal Outcomes in T2D With Intensive Glycemic Control in Veterans

Interim analysis of the follow-up Veterans Affairs Diabetes Trial study shows that intensive glycemic control for a median of 5.6 years may have a modest beneficial effect on delaying the progression of renal disease.

No Difference in Cardiovascular Outcomes With Exenatide vs Placebo in T2D

No Difference in Cardiovascular Outcomes With Exenatide vs Placebo in T2D

Once-weekly administration of extended-release exenatide in patients with T2D at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.

Increasing Body Surface Area Affected by Psoriasis May Increase T2D Risk

Increasing Body Surface Area Affected by Psoriasis May Increase T2D Risk

For patients with psoriasis, an increase in body surface area affected by the disease may be associated with a greater risk of type 2 diabetes.

Empagliflozin Reduces CVD Risk in Patients With T2D and PAD

Empagliflozin Reduces CVD Risk in Patients With T2D and PAD

Empagliflozin lowered the risk of cardiovascular death vs placebo when added to standard of care in adults with both type 2 diabetes and peripheral artery disease.

Brain Glucose Levels Blunted During Hyperglycemia in T2D and Obesity

Brain Glucose Levels Blunted During Hyperglycemia in T2D and Obesity

The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus.

Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes

Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes

A study of the once-weekly investigational dipeptidyl peptidase-4 omarigliptin reported a clinically meaningful reduction in glycated hemoglobin that was maintained throughout the study.

T2D in African American Women Ups ER-negative Breast Cancer Risk

T2D in African American Women Ups ER-negative Breast Cancer Risk

The high prevalence of T2D in African American women could explain previously identified racial disparities in breast cancer incidence.

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.

Insulin Glargine Associated With Breast Cancer Risk in T2D

Insulin Glargine Associated With Breast Cancer Risk in T2D

Researchers assessed whether long-term use of long-acting insulin analogs, compared with the use of neutral protamine Hagedorn insulin, is associated with an increased risk of breast cancer in women with T2D.

Change in Urine Albumin-to-Creatinine Ratio May Be a Prognostic Indicator in T2D

Change in Urine Albumin-to-Creatinine Ratio May Be a Prognostic Indicator in T2D

Albuminuria may be an effective prognostic indicator of adverse outcomes risk in patients with diabetes.

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.

Dementia Risk Reduced With Metformin in Veterans With T2D

Dementia Risk Reduced With Metformin in Veterans With T2D

Metformin is linked to a lower dementia risk compared to sulfonylureas among veterans with type 2 diabetes.

Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i

Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i

Researchers evaluated a meta-analysis of randomized controlled trials and an analysis of the FDA AE Reporting System to determine whether combination DPP4i/SGLT2i medication lowers risk of GUTI.

Efficacy of Oral and Subcutaneous Semaglutide in T2D

Efficacy of Oral and Subcutaneous Semaglutide in T2D

All dosages of oral semaglutide reduced mean HbA1c level significantly more than placebo by week 26.

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

People with type 2 diabetes and NOCS-NSTEMI who used incretin had a better prognosis than non-incretin users.

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.

Glucose Patterns and the Future Development of Diabetes

Glucose Patterns and the Future Development of Diabetes

Study revealed heterogeneity in plasma glucose response to oral glucose intake beyond the established glucose criteria based on fasting plasma glucose and 2 h post-load plasma glucose levels.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Rate of Undiagnosed Diabetes in the United States

Rate of Undiagnosed Diabetes in the United States

Undiagnosed diabetes is a relatively small fraction of the total diabetes population when a confirmatory definition is used.

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Second-line treatments are often initiated without first using first-line therapies.

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Studies have not previously examined long-term risks or mortality after aortic aneurysm or dissection in people with type 2 diabetes.

T2D and Magnesium Intake: Risk of Incident Diabetes Examined

T2D and Magnesium Intake: Risk of Incident Diabetes Examined

Higher magnesium intake was linked to a 15% lower risk for type 2 diabetes.

Cognitive Status in T2D: Retinal Sensitivity Predictive of Neurodegeneration

Cognitive Status in T2D: Retinal Sensitivity Predictive of Neurodegeneration

Retinal sensitivity, assessed by microperimetry, is related to brain neurodegeneration in T2D.

Diabetes Following Pancreatic Disease Often Misclassified as T2D

Diabetes Following Pancreatic Disease Often Misclassified as T2D

Diabetes following pancreatic disease often requires higher use of insulin and worse glycemic control.

Ventricular Function With Vildagliptin in T2D and CHF

Ventricular Function With Vildagliptin in T2D and CHF

Study highlights the need to examine the safety of new glucose-lowering treatments specifically in patients with diabetes and heart failure and reduced ejection fraction.

DPP4-i Plus α-Glucosidase Inhibitor Reduces HbA1c in T2D

DPP4-i Plus α-Glucosidase Inhibitor Reduces HbA1c in T2D

People with T2D experienced greater HbA1c reductions with the addition of a DPP4 inhibitor vs placebo.

SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents

SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents

A recent population-based study is the first to examine the risk of type 2 diabetes associated with the use of antidepressant medication in children and adolescents.

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

Based on glycemic control and treatment method, type 2 diabetes in the heart failure population can be indicative of various risk associations.

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Heart failure prevention may be an opportunity to reduce the risk of death in specific cardiovascular subcategories.

FDA Approves Exenatide Extended-Release Injection for T2D

FDA Approves Exenatide Extended-Release Injection for T2D

The new formulation of Bydureon BCise allows for once-weekly administration with an autoinjector pen.

Improved Outcomes in Prediabetes, T2D With Liraglutide

Improved Outcomes in Prediabetes, T2D With Liraglutide

The efficacy of liraglutide therapy was examined in metformin-treated subjects with obesity.

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

Greater prognostic advantages were associated with high-dose beta blockers in chronic heart failure with diabetes.

Reducing HbA1c in T1D and T2D With Flash Glucose Monitoring

Reducing HbA1c in T1D and T2D With Flash Glucose Monitoring

Overall reduction in HbA1c was higher in people with T2D vs those with T1D.

T2D Therapies: Tofogliflozin Efficacy With High Baseline Insulin

T2D Therapies: Tofogliflozin Efficacy With High Baseline Insulin

HbA1c, fasting plasma glucose, and body weight were significantly reduced in all patients taking tofogliflozin.

Trick or Treat: Tips for Diabetes Management on Halloween

Trick or Treat: Tips for Diabetes Management on Halloween

With a little communication, children with diabetes can still enjoy Halloween festivities.

Examining Melancholia and Atypical Depression in T1D and T2D

Examining Melancholia and Atypical Depression in T1D and T2D

Twenty-five percent of people with type 2 diabetes and 12% of people with type 1 diabetes had depression.

VA, DoD Release New T2D Clinical Practice Guideline

VA, DoD Release New T2D Clinical Practice Guideline

The update provides guidance within 7 areas of type 2 diabetes management, including patient centered care and individualized treatment plans.

Insulin Plus Sulfonylurea, Metformin Linked to HbA1c Reduction

Insulin Plus Sulfonylurea, Metformin Linked to HbA1c Reduction

However, sulfonylurea plus insulin was linked to more hypglycemic events than insulin alone.

Preventing T2D With Referral to Commercial Weight Management Program

Preventing T2D With Referral to Commercial Weight Management Program

Referral to a commercial weight management program, such as Weight Watchers, can be effective in preventing diabetes.

T2D Remission, Weigh Loss Associated With Roux-en-Y Surgery

T2D Remission, Weigh Loss Associated With Roux-en-Y Surgery

Researchers have identified lasting benefits for patients with severe obesity who undergo Roux-en-Y gastric bypass surgery.

Medicare Recipients Overtreated for Diabetes

Medicare Recipients Overtreated for Diabetes

For medicare recipients it is more common to be overtreated than undertreated for diabetes.

AMA: Encouraging Patients to Explore Diabetes Risk Through Tablet Use

AMA: Encouraging Patients to Explore Diabetes Risk Through Tablet Use

One clinic shares results after replacing magazines with tablets allowing patients to examine their risk of developing diabetes.

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Liraglutide plus usual care resulted in lower rates of diabetic kidney disease-specific outcomes in type 2 diabetes.

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Researchers identified several novel plasma biomarkers that can be used to predict rapid decline in renal function in T2D, independent of traditional risk factors.

Diabetes Self-Management Class Participation Varies in Adults with T2D

Diabetes Self-Management Class Participation Varies in Adults with T2D

Clinicians should identify barriers to patient participation in diabetes self-management classes.

Examining Inclusion of T2D Medication Adherence Data in Studies

Examining Inclusion of T2D Medication Adherence Data in Studies

Results suggest that medication adherence is associated with reduced risk of all-cause mortality in T2D.

Predicting Adult MetS, T2D, CV Risks in Childhood

Predicting Adult MetS, T2D, CV Risks in Childhood

BMI measurement alone can also be used to determine associations between childhood and adulthood conditions.

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Validation-tool identified "high risk" patients were more likely to report hypoglycemia episodes and subsequent emergence department use.

HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis

HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis

The efficacy of diagnosing diabetes or prediabetes using fasting plasma glucose vs traditional HbA1c test was examined.

Second-Generation Antipsychotics: Is Diabetes Risk Increased in Children and Adolescents?

Second-Generation Antipsychotics: Is Diabetes Risk Increased in Children and Adolescents?

The study included over 45,000 children using second-generation antipsychotic medications between 2009 and 2013.

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia.

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Patients with MACE showed a greater extent of more severe coronary artery disease.

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Researchers examined how adipocyte size reduction and fatty acid metabolism contribute to remission in type 2 diabetes following bariatric surgery.

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Diacerein was well-tolerated among trial participants, and may be an acceptable adjunct treatment in type 2 diabetes.

Counseling vs Standard Care to Increase Physical Activity in T2D

Counseling vs Standard Care to Increase Physical Activity in T2D

Three hundred physically inactive or sedentary patients received either theoretical and practical counseling once-yearly for 3 years, or standard care.

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Researchers identified strong inverse graded relationships between children's sleep duration, adiposity, and the presence of diabetes risk markers.

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

A retrospective analysis examined outcomes in patients with type 2 diabetes treated with SGLT2 vs DPP4 inhibitors.

Can Sustained Weight Loss Lead to Remission of T2D?

Can Sustained Weight Loss Lead to Remission of T2D?

Weight loss in people with type 2 diabetes is associated with extended life expectancy.

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Women with atrial fibrillation and diabetes had a higher risk for mortality and cardiovascular complications compared with men.

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Researchers examined the efficacy of cognitive behavioral group therapy on preventing weight regain or modifying cardiovascular risk factors and psychological well-being.

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Worsening glycemic status is linked to increased reports of individual cardiorespiratory symptoms, including dyspnea, cough, chest pain, and arrythmia.

Does PCOS Increase T2D Event Rate?

Does PCOS Increase T2D Event Rate?

Among women with polycystic ovary syndrome, type two diabetes was more common and diagnosed at a younger age than in control groups.

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Study results support an additional management method for glycemic control in patients with T2D.

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

Researchers examined the efficacy of lifestyle intervention on glycemic control in type 2 diabetes.

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Over 150 variables were identified as possible hypoglycemia risk factors.

Sign Up for Free e-Newsletters

CME Focus